Borderline personality disorder and substance use disorders: a review and integration.
about
Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related ConditionsDevelopment and validation of the Minnesota borderline personality disorder scaleEmotion-based dispositions to rash action: positive and negative urgencyTreatment for comorbid borderline personality disorder and alcohol use disorders: a review of the evidence and future recommendationsPsychophysiological assessment of emotional processing in patients with borderline personality disorder with and without comorbid substance use.A further validation of the Minnesota Borderline Personality Disorder Scale.Negative affect heightens opiate withdrawal-induced hyperalgesia in heroin dependent individualsEmotional conditions disrupt behavioral control among individuals with dysregulated personality traits.Balancing between sensitization and repression: the role of opium in the life and art of Edgar Allan Poe and Samuel Taylor Coleridge.Dialectical behavior therapy for substance abusersAre inmates' subjective sleep problems associated with borderline personality, psychopathy, and antisocial personality independent of depression and substance dependence?Day Hospital Mentalization-Based Treatment (MBT-DH) versus treatment as usual in the treatment of severe borderline personality disorder: protocol of a randomized controlled trial.The developmental psychopathology of alcohol use and alcohol disorders: research achievements and future directions.The relation between antisocial and borderline personality symptoms and early maladaptive schemas in a treatment seeking sample of male substance users.Understanding the heterogeneity of BPD symptoms through latent class analysis: initial results and clinical correlates among inner-city substance usersAnimal Modeling and Neurocircuitry of Dual Diagnosis.Validating female psychopathy subtypes: differences in personality, antisocial and violent behavior, substance abuse, trauma, and mental healthPain in patients with borderline personality disorderCo-occurring psychiatric symptoms are associated with increased psychological, social, and medical impairment in opioid dependent pregnant women.The association between catastrophizing and craving in patients with chronic pain prescribed opioid therapy: a preliminary analysis.Does comorbid substance use disorder exacerbate borderline personality features? A comparison of borderline personality disorder individuals with vs. without current substance dependenceThe Relationship Between Emotion Dysregulation and Deliberate Self-Harm Among Inpatients with Substance Use Disorders.IQ and schizophrenia in a Swedish national sample: their causal relationship and the interaction of IQ with genetic risk.Personality disorders and the persistence of substance use disorders: A reanalysis of published NESARC findings.Day hospital Mentalization-based treatment versus intensive outpatient Mentalization-based treatment for patients with severe borderline personality disorder: protocol of a multicentre randomized clinical trial.Distinguishing general and specific personality disorder features and implications for substance dependence comorbidity.Affect and alcohol use: an ecological momentary assessment study of outpatients with borderline personality disorder.Distress tolerance moderates the relationship between negative affect intensity with borderline personality disorder levels.Affect intensity and lability: the role of posttraumatic stress disorder symptoms in borderline personality disorderA Preliminary Examination of the Role of Emotion Differentiation in the Relationship between Borderline Personality and Urges for Maladaptive Behaviors.Deficits of affect mentalization in patients with drug addiction: theoretical and clinical aspectsClinical audit of women with substance use disorders: findings and implications.The impact of borderline personality disorder on residential substance abuse treatment dropout among men.Interaction between tryptophan hydroxylase I polymorphisms and childhood abuse is associated with increased risk for borderline personality disorder in adulthood.Psychiatric comorbidity and the persistence of drug use disorders in the United States.Associations in the course of personality disorders and Axis I disorders over timePathways to Vulnerability for Alcohol Problem Severity in a Treatment-Seeking Sample.Ovarian hormones and borderline personality disorder features: Preliminary evidence for interactive effects of estradiol and progesterone.The prevalence of substance use disorders and psychiatric disorders as a function of psychotic symptoms.Borderline personality symptoms in short-term and long-term abstinent alcohol dependence
P2860
Q22241102-9254F5A8-6788-4D1B-94C6-DED574AF29C4Q24633955-B38BDCE3-FAE8-4175-BC57-8716D2ED412AQ24652826-0467A766-252B-46A6-8A5E-65BD9DA1CDC3Q27002357-7E1DE0F7-0770-4D7A-99AE-DC9F242BDD8AQ30435229-376A52BF-7FA3-452E-9831-A451A2BA6E50Q30457262-A0E7AFD0-4C9B-44DB-9307-153C57512180Q30466178-1396BD49-FB2C-4B67-96F5-96BB53AD76DBQ30475643-5CB95F07-8B6B-4BDE-915B-0E651BC55CA3Q33451648-B7EB93FC-737C-4BDF-BF76-96D2CEBC009EQ33553137-5D2C3B42-EB93-4BC5-BB27-2F1757C8346BQ33694067-85AC851F-5D38-4229-9F26-DC73044C5E72Q33712671-6C69833C-F4DA-404D-8EE6-097BA61A62E0Q33842150-7CFD8511-5F3E-49E7-9493-2AFB176FDF6EQ33882367-35D01CF3-2FCA-4D04-896D-04A3FA6E4C9EQ33906443-D326B7F5-237E-465F-96E9-8BFD355E42A6Q33922939-06F85C6D-7293-4F75-9C4D-83B28A0AD26AQ33929990-FBCF9505-3D4D-4B9A-BDD8-4642541E1DA6Q34030942-D42A2911-9771-4CF7-9482-9BE88F96CDD2Q34076552-D3280FEA-80D2-4C57-907E-3B4B17F368B1Q34161065-2D44C8BA-E472-408A-A349-44FEAAFC5520Q34352918-32530969-1452-4E6E-A7B7-806A975E613FQ34373707-A6F77A3D-F5D0-4D1E-810E-C87AAFF554A7Q34465094-BD4773E4-C5DF-4F6F-BF54-E88E3937496BQ34498313-389A409C-0AC8-4CBE-8DDA-D4A80FDD2005Q34558784-662F5C06-AF0C-4997-B604-B2119D89A32BQ34559452-72CC3F3D-AD33-446A-818A-BE83F6F82E46Q34673027-89A0C545-E424-4A15-B346-7E5E56E804D8Q34892174-6C2615D7-5D77-4ED2-B897-79FB3ED1E55DQ34919766-64D6E9A5-558D-4B92-BB16-C95AF5C99089Q35137195-E37AC981-0007-4564-A539-3A7B930D60DAQ35361249-F655A5E1-6429-4D9F-A231-818DBAAD8A21Q35564984-DBBDDB54-A85F-4F60-BA3C-057124AC74DFQ35613401-13590A70-7180-4439-A14E-1F9EAB205AF3Q35621671-ACCAF37A-C464-4C94-9A0B-1396234C156AQ35678302-A6D48EBC-DAEB-40AB-9EA0-4627D8AA1D5DQ35743312-64D2E224-C00D-4C36-8E5F-DC092553083AQ35838634-39CEAD94-736C-467D-A4F8-A516F8D27E1CQ35893833-E9868448-234C-48B6-A4BB-36946938480EQ35911194-90AAC148-C2F9-43E7-BC87-9EFABB18FC19Q35951671-B811A3B3-B98A-4842-AE3B-96A30F2A3818
P2860
Borderline personality disorder and substance use disorders: a review and integration.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Borderline personality disorder and substance use disorders: a review and integration.
@ast
Borderline personality disorder and substance use disorders: a review and integration.
@en
type
label
Borderline personality disorder and substance use disorders: a review and integration.
@ast
Borderline personality disorder and substance use disorders: a review and integration.
@en
prefLabel
Borderline personality disorder and substance use disorders: a review and integration.
@ast
Borderline personality disorder and substance use disorders: a review and integration.
@en
P2093
P1476
Borderline personality disorder and substance use disorders: a review and integration.
@en
P2093
P304
P356
10.1016/S0272-7358(99)00028-8
P577
2000-03-01T00:00:00Z